William N. Hait - Articles and news items

Janssen Pharmaceuticals Logo

Janssen Biotech, Inc. announces collaborative development and worldwide license agreement for investigational anti-cancer drug, PCI-32765

Industry news, News / 8 December 2011 / Johnson & Johnson

Compound in development for multiple B-cell hematologic malignancies…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+